D-二聚体与纤维蛋白原联合静脉通畅度评分在下肢深静脉血栓置管溶栓中的应用价值

朱威; 卢冉; 余朝文; 聂中林; 陈世远; 宋涛

doi:10.16766/j.cnki.issn.1674-4152.002493

D-二聚体与纤维蛋白原联合静脉通畅度评分在下肢深静脉血栓置管溶栓中的应用价值

doi: 10.16766/j.cnki.issn.1674-4152.002493

蚌埠医学院第一附属医院血管外科，安徽蚌埠 233004

基金项目:

安徽省高校自然科学研究项目 KJ2019A0327

蚌埠医学院创新计划项目 Byycxz20049

详细信息

通讯作者:
卢冉, E-mail: luran2406@sina.com

中图分类号: R654.4R543.6
计量
- 文章访问数: 206
- HTML全文浏览量: 88
- PDF下载量: 2
- 被引次数: 0
出版历程
- 收稿日期: 2021-09-30
- 网络出版日期: 2022-09-21

Application value of D-dimer and fibrinogen combined with venous patency score in thrombolysis of deep venous thrombosis of lower extremities

Department of Vascular Surgery, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China

摘要

摘要: 目的分析下肢深静脉血栓行置管溶栓(CDT)过程中监测D-二聚体、纤维蛋白原和静脉通畅度评分的变化，评估其临床应用价值。方法选取2019年6月—2021年6月在蚌埠医学院第一附属医院被确诊为急性下肢深静脉血栓的37例患者作为研究对象，患者均进行了下腔静脉滤器置入术、抗凝、置管溶栓等治疗，在治疗过程中测量并记录术前1 d、术后每天监测2次D-二聚体、纤维蛋白原至术后7 d，计算置管溶栓术前1 d、术后3 d、术后7 d的静脉通畅度评分。结果 37例患者在行置管溶栓过程中均未出现呼吸困难、咯血、胸痛等肺栓塞症状。本治疗组中有2例患者出现腘窝穿刺点出血，1例患者出现牙龈出血，未予特殊处理，均未出现严重出血等并发症。在下肢深静脉血栓行置管溶栓过程中，D-二聚体平均值在DVT溶栓过程中先呈升高趋势，在术后2 d达最高水平，最高值为77.4 mg/L，此后逐渐下降至正常水平，纤维蛋白原平均值在置管溶栓过程中总体呈现下降趋势。术后3 d静脉通畅度评分为(3.7±0.9)分，术后7 d通畅度评分为(2.4±0.7)分，差异有统计学意义(P＜0.05)。结论在下肢深静脉血栓置管溶栓过程中，D-二聚体可以作为监测溶栓时间及治疗效果的指标，纤维蛋白原可以作为监测停止溶栓和出血情况的指标，静脉通畅度评分的变化可以作为血栓清除的指标。
- 下肢深静脉血栓形成 /
- 置管溶栓 /
- D-二聚体 /
- 纤维蛋白原
Abstract: Objective To analyze the changes of D-dimer, fibrinogen and venous patency score during catheter-directed thrombolysis (CDT) in deep venous thrombosis of lower limbs, and to evaluate their clinical application value. Methods Thirty-seven patients diagnosed with acute lower extremity deep vein thrombosis at the First Affiliated Hospital of Bengbu Medical College from June 2019 to June 2021 were included as the research objects. All patients were treated with inferior vena cava filter surgery, anticoagulation and CDT. During the treatment, D-dimer and fibrinogen were measured and recorded 1 day before operation and twice a day after operation until 7 days after operation, and the venous patency scores were calculated 1 day before operation, 3 days after operation and 7 days after catheter thrombolysis. Results None of the 37 patients had pulmonary embolism symptoms such as dyspnoea, haemoptysis and chest pain during CDT. In this treatment group, there were 2 patients with popliteal puncture site bleeding, 1 patient with gingival bleeding, without special treatment, and no serious bleeding and other complications. In the process of CDT for deep vein thrombosis of lower limbs, the average value of D-dimer firstly increased during DVT thrombolytic process, and reached the highest level at 77.4 mg/L two days after the operation, and then gradually decreased to the normal level. The average value of fibrinogen generally showed a downward trend during DVT thrombolytic process. The venous patency score was (3.7±0.9) points 3 days after surgery, and (2.4±0.7) points 7 days after surgery, the difference was statistically significant (P < 0.05). Conclusion D-dimer can be used to monitor thrombolysis time and therapeutic effect, fibrinogen can be used to monitor thrombolysis stop and bleeding, and the change of venous patency score can be used as an indicator of thrombus clearance in the process of CDT in deep vein thrombosis of lower limbs.
- Lower extremity deep vein thrombosis /
- Catheter-directed thrombolysis /
- D-dimer /
- Fibrinogen

HTML全文

图 1 溶栓过程中D-二聚体、纤维蛋白原均值变化趋势图

Figure 1. Trend of mean change of D-dimer and fibrinogen during thrombolytic treatment

下载: 全尺寸图片幻灯片

参考文献(20)

[1]	HATTAB Y, KVNG S, FASANYA A, et al. Deep venous thrombosis of the upper and lower extremity[J]. Crit Care Nurs Q, 2017, 40(3): 230-236. doi: 10.1097/CNQ.0000000000000165
[2]	VEDANTHAM S, GRASSI C J, FERRAL H, et al. Technology assessment committe of the society of interventional radiology. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis[J]. J Vasc Interv Radiol, 2006, 17(3): 417-434. doi: 10.1097/01.RVI.0000197359.26571.C2
[3]	ABRAHAM B, SEDHOM R, MEGALY M, et al. Outcomes with catheter-directed thrombolysis compared with anticoagulation alone in patients with acute deep venous thrombosis[J]. Catheter Cardiovasc Interv, 2021, 97(1): E61-E70.
[4]	WANG L, ZHANG C L, MU S Y, et al. Catheter-directed thrombolysis for patients with acute lower extremity deep vein thrombosis: a meta-analysis[J]. Rev Latino-Am Enfermagem, 2018, 26: e2990. DOI: 10.1590/1518-8345.2309.2990.
[5]	XU Y D, ZHONG B Y, YANG C, et al. Comparison of catheter-directed thrombolysis with and without percutaneous mechanical thrombectomy for subacute iliofemoral deep vein thrombosis[J]. Phlebology, 2020, 35(8): 589-596. doi: 10.1177/0268355520919201
[6]	PASHA A K, SIDDIQUI M U, SIDDIQUI M D, et al. Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: A systematic review and meta-analysis[J]. J Thromb Thrombolysis, 2022, 53(2): 454-466. doi: 10.1007/s11239-021-02556-7
[7]	中国医师协会介入医师分会, 中华医学会放射学分会介入专业委员会, 中国静脉介入联盟. 下肢深静脉血栓形成介入治疗规范的专家共识(第2版)[J]. 介入放射学杂志, 2019, 28(1): 1-10. doi: 10.3969/j.issn.1008-794X.2019.01.001 Branch of Interventional Physicians of Chinese Medical Doctor Association, Interventional Professional Committee of Radiology Society of Chinese Medical Association, Chinese Intravenous interventional Alliance. Expert consensus on interventional treatment of lower extremity deep vein thrombosis (2nd Ed. )[J]. Journal of Interventional Radiology, 2019, 28(1): 1-10. doi: 10.3969/j.issn.1008-794X.2019.01.001
[8]	LIU M, ZHANG F X. Administration routes affect thrombolytic effect of catheter-directed thrombolysis with pro-urokinase in treating deep vein thrombosis[J]. Ann Transl med, 2018, 6(16): 322. doi: 10.21037/atm.2018.08.01
[9]	刘强, 程英升, 王永利, 等. D-二聚体及纤维蛋白原监测在导管接触溶栓治疗急性下肢深静脉血栓形成中的应用[J]. 介入放射学杂志, 2018, 27(11): 1031-1035. doi: 10.3969/j.issn.1008-794X.2018.11.005 LIU Q, CHENG Y S, WANG Y L. The application of monitoring of plasma D-dimer and fibrinogen concentrations in treating acute lower extremity deep venous thrombosis with catheter-directed thrombolysis[J]. Journal of Interventional Radiology, 2018, 27(11): 1031-1035. doi: 10.3969/j.issn.1008-794X.2018.11.005
[10]	LIU X C, XIE H L, ZHENG G F, et al. The plasma D-dimer trends and their value in acute lower limb ischemia patients treated by catheter directed thrombolysis[J]. Sci Rep, 2021, 11(1): 10388. doi: 10.1038/s41598-021-89905-x
[11]	LI Y H, WANG J W, HE R Z, et al. Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis[J]. Thromb J, 2021, 19(1): 6. doi: 10.1186/s12959-021-00260-3
[12]	中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中华血管外科杂志, 2017, 2(4): 201-208. https://www.cnki.com.cn/Article/CJFDTOTAL-XGWK201704005.htm Vascular Surgery Group, Chinese Society of Surgery Medical Association. Diagnosis and treatment of deep vein thrombosis (3rd Ed. )[J]. Chinese Journal of Vascular Surgery, 2017, 2(4): 201-208. https://www.cnki.com.cn/Article/CJFDTOTAL-XGWK201704005.htm
[13]	HAYWOOD H B, PAULEY E, ORGEL R, et al. Fibrinogen levels and bleeding risk in patients undergoing ultrasound-assisted catheter-directed thrombolysis for submassive pulmonary embolism[J]. J Invasive Cardiol, 2021, 33(9): E702-E708.
[14]	GRAIF A, GRILLI C J, KIMBIRIS G, et al. Evaluation of fibrinogen levels during catheter-directed thrombolysis for acute pulmonary embolism[J]. J Vasc Interv Radiol, 2020, 31(8): 1281-1289. doi: 10.1016/j.jvir.2020.04.032
[15]	陈海瑞, 张剑平, 王孝高, 等. 不同给药方法在下肢深静脉血栓导管溶栓过程中的对比研究[J]. 中华全科医学, 2021, 19(5): 782-785. doi: 10.16766/j.cnki.issn.1674-4152.001916 CHEN H R, ZHANG J P, WANG X G, et al. Comparative study of different drug delivery methods in the catheter-directed thrombectomy for deep venous thrombosis in lower extremities[J]. Chinese Journal of General Practice, 2021, 19(5): 782-785. doi: 10.16766/j.cnki.issn.1674-4152.001916
[16]	康涛, 陆耀良, 李晓强, 等. AngioJet血栓清除联合置管溶栓治疗下肢深静脉血栓形成的疗效分析[J]. 中国血管外科杂志(电子版), 2019, 11(2): 123-127. doi: 10.3969/j.issn.1674-7429.2019.02.011 KANG T, LU Y L, LI X Q, et al. Efficacy analysis of AngioJet thrombectomy combined with catheter directed thrombolysis in treatment of lower extremity deep vein thrombosis[J]. Chinese Journal of Vascular Surgery(Electronic Version), 2019, 11(2): 123-127. doi: 10.3969/j.issn.1674-7429.2019.02.011
[17]	霍艳兵, 赵忠良. 不同入路置管溶栓治疗急性下肢深静脉血栓患者的临床疗效[J]. 血管与腔内血管外科杂志, 2020, 6(2): 120-123, 131. https://www.cnki.com.cn/Article/CJFDTOTAL-XGQW202002008.htm HUO Y B, ZHAO Z L. Clinical effect of thrombolysis with different approaches in patients with acute lower extremity deep vein thrombosis[J]. Journal of Vascular and Endovascular Surgery, 2020, 6(2): 120-123, 131. https://www.cnki.com.cn/Article/CJFDTOTAL-XGQW202002008.htm
[18]	LEE J K, KIM K Y, BYUN S J, et al. Safety and efficacy of aspiration thrombectomy or pharmacomechanical thrombectomy after catheter-directed thrombolysis for the Treatment of Acute Iliofemoral Deep Vein Thrombosis[J]. Vasc Specialist Int, 2020, 36(3): 144-150. doi: 10.5758/vsi.200041
[19]	XU Y, WANG X, SHANG D, et al. Outcome of AngioJet mechanical thrombus aspiration in the treatment of acute lower extremities deep venous thrombosis[J]. Vascular, 2021, 29(3): 415-423. doi: 10.1177/1708538120958595
[20]	NAKAMURA H, ANZAI H, KADOTANI M, et al. Less frequent post-thrombotic syndrome after successful catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis[J]. Cardiovasc Interv Ther, 2021, 36(2): 237-245. doi: 10.1007/s12928-020-00661-7